Dr. Mark Cormier, M.D

Urology Rockford, IL Male
NPI: 1922078401
Total Payments
$85,271
2024 Payments
$60,701
Companies
27
Transactions
127
Medicare Patients
4,220
Medicare Billing
$347,126

Payment Breakdown by Category

Consulting$82,800 (97.1%)
Food & Beverage$1,941 (2.3%)
Education$475.00 (0.6%)
Travel$55.02 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $82,800 28 97.1%
Food and Beverage $1,941 97 2.3%
Education $475.00 1 0.6%
Travel and Lodging $55.02 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $83,330 30 $0 (2024)
Astellas Pharma US Inc $378.74 28 $0 (2024)
Janssen Biotech, Inc. $208.62 8 $0 (2022)
Dendreon Pharmaceuticals LLC $196.03 5 $0 (2021)
Myovant Sciences Inc. $153.43 9 $0 (2022)
Verity Pharmaceuticals Inc. $148.16 8 $0 (2024)
Bayer HealthCare Pharmaceuticals Inc. $125.00 1 $0 (2020)
AbbVie Inc. $98.63 6 $0 (2021)
Coloplast Corp $88.17 5 $0 (2022)
Sumitomo Pharma America, Inc. $83.74 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $60,701 22 Takeda Pharmaceuticals U.S.A., Inc. ($60,667)
2023 $22,843 18 Takeda Pharmaceuticals U.S.A., Inc. ($22,663)
2022 $374.74 19 Myovant Sciences Inc. ($153.43)
2021 $306.72 16 Dendreon Pharmaceuticals LLC ($69.43)
2020 $253.32 9 Bayer HealthCare Pharmaceuticals Inc. ($125.00)
2019 $318.94 17 Astellas Pharma US Inc ($114.22)
2018 $311.41 16 Astellas Pharma US Inc ($125.85)
2017 $161.17 10 Astellas Pharma US Inc ($41.31)

All Payment Transactions

127 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
03/13/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $14.50 General
Category: Oncology
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
03/11/2024 Verity Pharmaceuticals Inc. Trelstar (Drug) Food and Beverage Cash or cash equivalent $19.91 General
Category: Prostate cancer
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
11/27/2023 Verity Pharmaceuticals Inc. Trelstar (Drug) Food and Beverage Cash or cash equivalent $19.52 General
Category: Prostate cancer
11/10/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,033.33 General
123…6»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 16 907 1,305 $359,729 $66,363
2021 23 1,519 4,511 $633,878 $129,597
2020 25 1,794 4,314 $724,675 $151,167
Total Patients
4,220
Total Services
10,130
Medicare Billing
$347,126
Procedure Codes
64

All Medicare Procedures & Services

64 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2022 30 198 $198,000 $27,029 13.7%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 50 61 $35,990 $10,417 28.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 150 182 $31,850 $10,345 32.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 57 60 $15,000 $5,295 35.3%
51702 Simple insertion of temporary bladder tube Office 2022 16 54 $13,284 $2,047 15.4%
84153 Psa (prostate specific antigen) measurement, total Office 2022 89 114 $11,400 $2,043 17.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $7,125 $1,882 26.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 21 21 $5,880 $1,608 27.3%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 21 22 $2,860 $1,230 43.0%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 13 14 $2,240 $1,064 47.5%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2022 32 37 $4,810 $873.41 18.2%
81003 Automated urinalysis test Office 2022 207 287 $8,897 $634.64 7.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 16 17 $2,040 $621.48 30.5%
51798 Ultrasound measurement of bladder capacity after voiding Office 2022 73 79 $15,168 $547.48 3.6%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 22 23 $1,909 $378.12 19.8%
36415 Insertion of needle into vein for collection of blood sample Office 2022 91 117 $3,276 $347.37 10.6%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2021 33 288 $288,000 $39,746 13.8%
52000 Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope Office 2021 86 120 $70,800 $20,595 29.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 210 260 $45,500 $15,880 34.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 95 105 $26,250 $9,703 37.0%
J9030 Bcg live intravesical instillation, 1 mg Office 2021 20 2,250 $15,480 $4,861 31.4%
64566 Implantation of lower leg neurostimulator electrode, accessed through the skin Office 2021 19 50 $15,000 $4,340 28.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 35 35 $13,125 $4,329 33.0%
51702 Insertion of indwelling bladder catheter, simple Office 2021 40 81 $19,926 $3,760 18.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 49 54 $6,914 $3,651 52.8%
123»

About Dr. Mark Cormier, M.D

Dr. Mark Cormier, M.D is a Urology healthcare provider based in Rockford, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922078401.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Cormier, M.D has received a total of $85,271 in payments from pharmaceutical and medical device companies, with $60,701 received in 2024. These payments were reported across 127 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($82,800).

As a Medicare-enrolled provider, Cormier has provided services to 4,220 Medicare beneficiaries, totaling 10,130 services with total Medicare billing of $347,126. Data is available for 3 years (2020–2022), covering 64 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Rockford, IL
  • Active Since 01/25/2006
  • Last Updated 11/19/2009
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1922078401

Products in Payments

  • ORGOVYX (Drug) $237.17
  • XTANDI (Drug) $217.53
  • PROVENGE (Drug) $196.03
  • Trelstar (Drug) $148.16
  • Xofigo (Drug) $125.00
  • Erleada (Drug) $99.96
  • MYRBETRIQ (Drug) $89.86
  • (815) Thiola (Drug) $78.18
  • ERLEADA (Drug) $72.74
  • LUPRON DEPOT (Drug) $66.88
  • Myrbetriq (Drug) $56.85
  • SpeediCath (Device) $43.23
  • ZYTIGA (Drug) $35.92
  • NANOKNIFE (Device) $32.37
  • Dornier Medilas H Solvo (Device) $31.24
  • PROGEL (Device) $31.18
  • SPEEDICATH (Device) $27.51
  • VIAGRA (Drug) $26.62
  • BMD-Magic3 Catheter (Device) $18.99
  • Lupron Depot (Drug) $18.82

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Rockford

Douglas Roegner, M.d, M.D

Urology — Payments: $10,425

Urology $10,425

Michael Fumo, M.d, M.D

Urology — Payments: $7,990

Urology $7,990

Daniel Houlihan, D.o, D.O

Urology — Payments: $4,256

Urology $4,256

Dr. Luke Frederick, Md, MD

Urology — Payments: $4,024

Urology $4,024

Christopher Whelan, Md, MD

Urology — Payments: $2,404

Urology $2,404

Richard Valadez, M.d, M.D

Urology — Payments: $1,555

Urology $1,555